New Concepts for Valuation of Portfolios of Intellectual Property Asset Classes: LPBI Group – A Case in Point
Author and Curator of own ideas and contents: Aviva Lev-Ari, PhD, RN, Founder of 1.0 LPBI and of 2.0 LPBI Group
I acknowledge inputs to this article from:
Erich Greenbaum, the references to DAO and IP-NFT
Dr. Ofer Markman, comments on the Table
Prof. Stephen J. Williams, comments on the Table and on the applicability of IP-NFT concept to LPBI Group’s Portfolio of IP.
Updated on 11/22/2025
- AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class I: PharmaceuticalIntelligence.com Journal, 2.5MM Views, 6,250 Scientific articles and Live Ontology
- AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class II: 48 e-Books: English Edition & Spanish Edition. 152,000 pages downloaded under pay-per-view
- AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class III: 100 e-Proceedings and 50 Tweet Collections of Top Biotech and Medical Global Conferences, 2013-2025
Biological Images – Art Galley in the WordPress Cloud, privileged access via Dashboard
- AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class V: 7,500 Biological Images in LPBI Group’s Digital Art Media Gallery, as Prior Art
- AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class X: +300 Audio Podcasts Library: Interviews with Scientific Leaders
Updated on 8/30/2025
August 30, 2025 – All times
Views – 2,416,988
Visitors – 1,521,882
Scientific articles (Posts) – 6,245
Updated on 8/22/2025
In the Artificial Intelligence (AI) ERA
- We pioneered since 2021, applications of AI: Machine Learning (ML) and Natural Language Processing (NLP) for Medical Text analysis on our own content. We published two books with the results of AI algorithms. We teamed up with Linguamatics, now IQVIA for application of their proprietary NLP on 30 articles of ours with outstanding results [Our content was the Training Data rather than using PubMed articles as Training Data]
- We explained that AI ERA is moving very fast since (a) ChatGPT launched on 11/2024, (b) DeepSeek on 2/2025, (c) GPT 5 on 8/2025, and (d) Grok 4 & Imagine on 8/2025
- We explained that LPBI Group’s IP Portfolio needs to be positioned as TRAINING DATA for AI Modeling in the Healthcare domain as we published in the article
Mission: Design of an Artificial Intelligence [AI-built] Healthcare Foundation Model driven by and derived from Medical Expert Content generated by LPBI Group’s Experts, Authors, Writers (EAWs) used as Training Data for the Model
https://pharmaceuticalintelligence.com/healthcare-foundation-model/
- Meaning that Scientific Publishers are less important as a Targeted sector to find an acquirer for the IP Portfolio
- However, IT Companies with Healthcare Applications using AI, i.e., Oracle, Microsoft, Apple, Amazon, Google, NVIDIA are MOST important
We have also produced the article
LPBI Group’s Legacy and Biography of Aviva Lev-Ari, PhD, RN, Founder & Director – INTERACTIVE CHAT with Grok, created by xAI
- Privately-held not like PubMed in the Public Domain already used and exhausted by all AI companies
- We are Debt FREE
- Nine Giga Bytes of Digital Data is in the Cloud: Journal and the rest IP Assets are on the Cloud of WordPress.com
- All 48 published books are on Amazon.com
- Royalties are deposited every 90 days by Amazon to LPBI Group’s Citizens Bank Account in Newton, MA
Updated on 8/15/2025
Portfolio STATISTICS UPDATED on 5/16/2025 – NUMBERS CHANGES every day
Statistics Updated
- Portfolio of IP Assets
https://pharmaceuticalintelligence.com/portfolio-of-ip-assets/
August 15, 2025 – All times
Views – 2,407,743
Visitors – 1,517,847
Scientific articles (Posts) – 6,245
UPDATED on 5/16/2025
>>> IP Asset Class VIII – 5/15/2025 – 18,000 subscribers – Annual Update in 1/2026
>>> IP Asset Class VII – 5/15/2025 – 151,050 page downloads from e-Books. 8/2025 – 155,000 page downloads from e-Books.
[17 e-Books English Edition, 19 e-Books Spanish Edition, 1 Library of Podcasts, 10 bundled series: 5 English Edition, 5 Spanish Edition]
>>> IP Asset Class I – 5/16/2025 – Journal [On 5/16/2025 All-time stats] http://pharmaceuticalintelligence.com
May 16, 2025
Views – 2,390,102
Visitors – 1,508,829
Scientific articles (Posts) – 6,233
UPDATED on 2/15/2024
UPDATED on 4/7/2023
- Click on 1st Link for page 1
- Click on 2nd Link for page 2
- Click on Image of page 1
- Click on Image of page 2
- Adjust size to 200% page 1 and page 2
4-7-2023 – LPBI Portfolio of IP Valuation Aviva and SJW_p1
4-7-2023 – LPBI Portfolio of IP Valuation Aviva and SJW_p2
Updated on 2/25/2022 [ON HOLD, 3/2023]
We equate a major portion of LPBI Group’s Portfolio of Intellectual Properties to have the potential to be #SNFT aka, SCIENTIFIC NON FUNGIBLE TOKENS: Examples
- one journal article of the curation type,
- one image in the gallery,
- one book: English or Spanish Edition
- one article in a book,
- one chapter of 10 articles in a book.
- one Series in the English Edition:
Series A, six volumes, cardiovascular
Series B, two volumes, Genomics
Series C, two volumes, Cancer
Series D, four volumes, Immunology
Series E, four volumes, Precision Medicine
- one Series in the Spanish Edition: A,B,C,D,E
Series A, six volumes, cardiovascular
Series B, three volumes, Genomics
Series C, two volumes, Cancer
Series D, four volumes, Immunology
Series E, four volumes, Precision Medicine
We define smart contracts for dissemination of #SNFT as
the #liquidity of Scientific #knowledge
LPBI Group’s Portfolio of IP Assets as #SNFT include:
IP Asset Class I (+6K #SNFT)
- All the article curations in LPBI Group’s +6,100 scientific #articles in PharmaceuticalIntelligence.com
IP Asset Class II
- All electronic Table of Contents (eTOCs) of 18 Books in Medicine, aka BioMed e-Series
https://lnkd.in/ekWGNqA
- All eTOCs in Spanish Audio
- All eTOCs in Bi-Lingual English-Spanish Text
- All eTOCs in English Text
- All Cover Pages of 18 Books in Medicine – English Edition
IP Asset Class XII using inputs from IP Asset Class II
- All Cover Pages of 18 Books in Medicine – Spanish Translation by Series:
Series A: Cardiovascular – 6 volumes
Series B: Genomics – 2 volumes
Series C: Cancer – 2 volumes
Series D: Immunology – 4 volumes
Series E: Precision Medicine
- All Editorials of 18 Books – English Text
- All Editorials of 18 Books – English Audio
IP Asset Class V (+6K #SNFT)
- All Biological Images in Books, 18 volumes
- All Legends of images in Text format – considered for Text Analysis with Machine learning
- Gallery of Biological Images +6200
- Biological Images in Journal articles https://lnkd.in/eteNqpF not in Books
IP Asset Class XII – Part B of New Genre of Scientific Books
- Text Analysis with AI, Machine Learning – Natural Language Processing (NLP) Statistical & Deep Learning (DL) on
– Two books in Genomics
– Two books in Cancer & Oncology
- Graphic results of NLP and DL:
– Hypergraph Plots, one graph per Chapter and Expert interpretation text
– Tree Diagram Plots, one graph per Chapter and Expert interpretation text
IP Asset Class III
• 100 e-Proceedings of Biotech conferences
• 40 Tweet Collections of 40 of the 100 conferences
#oncology #biotech #medicine #ai #deeplearning #machinelearning #nlp #genomics #translation #graphic #hypergraph #cardiovascular #immunology #precisionmedicine #cancer #intellectualproperty
2.0 LPBI Missions
Four missions as LPBI’s exposition of the pipelines for 2021 -2025:
Mission #1: NLP – Team in USA & India – Medical Text Analysis with NLP – on LPBI 3.3 Giga Bytes of Content. Statistical NLP and Deep Learning by Machine Learning using Wolfram Language for Biological Sciences
Mission #2: Blockchain IT and NLP Processing API generating NLP visualization Products used by Knowledge Graphs stored in Graph Databases – Content monetization infrastructure B2B and B2C.
Mission #3: BioMed e-Books – Book Republishing in new GENRE – Bi-Lingual and Multimedia Audio Podcast for Books in the 18-e-Books in five e-Series: A,B,C,D,E
Mission #4: Synthetic Biology Software: Drug discovery Galectins
2.0 LPBI is a Very Unique Organization
Author: Aviva Lev-Ari, PhD, RN, Founder of 1.0 LPBI and 2.0 LPBI, April 2012 to Present
LPBI Group’s Portfolio of 14 Intellectual Property Asset Classes
Two New Concepts in Valuation of IP Asset Classes: DAO and IP-NFT
Please review these two articles before reviewing the Table, below
What is a decentralized autonomous organization, and how does a DAO work?
https://cointelegraph.com/ethereum-for-beginners/what-is-a-decentralized-autonomous-organization-and-how-does-a-dao-work
IP-NFTs for Researchers: A New Biomedical Funding Paradigm
https://medium.com/molecule-blog/ip-nfts-for-researchers-a-new-biomedical-funding-paradigm-91312d8d92e6
How do we see applicability of NFT to LPBI Group’s Intellectual Property Portfolio?
Data in tables updated on November 14, 2021
Data represent the views of LPBI Group’s Founder
For a detailed description of 1.0 LPBI Portfolio of IP Assets please review
1.0 LPBI 2012-2020 VISTA
For a detailed description of 2.0 LPBI Portfolio of IP Assets please review
2.0 LPBI 2021-2025 VISION
In the Voice of Dr. Williams
See the columns under Dr. Williams Name
The reasoning will be discussed below but first the reader is directed to the two links: one a video and the second a blog on NFT Assets and Business Exits
Please View Video
The whole point of NFT is that the word “fungible” can also mean replacable so a non fungible asset cannot be replaced or even reproduced. Think of the Mona Lisa. It can be reproduced but not by the original artist so there is only one first nonfungible Mona Lisa.
This NFT concept works well in the art world but for assets you want to reproduce and sell over and over this concept is very poor and would not work well at all. It is a tempting idea for assests which may not have an ideal way to sell however most of LPBI assest are in fact, fungible.
Other related articles on this Open Access Online Scientific Journal to this topic include the following:
Data Architecture for Blockchain Deployment of Digital Assets: LPBI IP Asset Classes I,II,III,V
Author: Aviva Lev-Ari, PhD, RN
February 1, 2021 – We Celebrate 1,924,400 e-Readers, 6,000 Scientific Journal Articles, 7,525 Scientific Comments, A Journal Ontology of 728 Medical & Life Sciences Research Categories, 10,440 Tags, Top Article 17,300 Views, Top Author 487,500 Views on PharmaceuticalIntelligence.com
Reporter: Aviva Lev-Ari, PhD, RN
Update on 7/1/2021 by Srinivas Sriram and Abhisar Anand
The Map of human proteins drawn by artificial intelligence and PROTAC (proteolysis targeting chimeras) Technology for Drug Discovery
Curators: Dr. Stephen J. Williams and Aviva Lev-Ari, PhD, RN
UPDATED on 11/5/2021
WORKFLOW for a Ten-Steps Medical Text Analysis Operation using NLP on LPBI Medical and Life Sciences Content
Author: Aviva Lev-Ari, PhD, RN with inputs related to Wolfram NLP Code by Madison Davis and Yash Choudhary
This page has the following sub pages.
2012pharmaceutical
sjwilliamspa